OverviewSuggest Edit

Penumbra designs, develops, manufactures, and markets medical devices. The Company offers neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies, aspiration based thrombectomy systems and accessory devices, and revascularization device for mechanical thrombectomy. It also provides neurovascular embolization coiling systems and neurovascular stents. In addition, the Company offers neurosurgical aspiration tools and detachable embolic coil systems and microcatheter devices.

TypePublic
Founded2004
HQAlameda, US
Websitepenumbrainc.com
Employee Ratings3.4

Latest Updates

Employees (est.) (Dec 2018)2,200(+30%)
Job Openings43
Revenue (FY, 2018)$444.9 M(+34%)
Share Price (Mar 2019)$158 (-1%)

Penumbra Office Locations

Penumbra has offices in Alameda, New York, Melbourne, Livermore and in 6 other locations
Alameda, US (HQ)
1321 Harbor Bay Pkwy
Alameda, US
1351 Harbor Bay Pkwy
Atlanta, US
Atlanta, GA, USA
Chicago, US
Chicago, IL, USA
Livermore, US
Livermore, CA, USA
Melbourne, US
Melbourne, FL, USA
Show all (12)
Report incorrect company information

Penumbra Financials and Metrics

Penumbra Revenue

Penumbra's revenue was reported to be $444.94 m in FY, 2018
USD

Revenue (FY, 2018)

444.9m

Gross profit (FY, 2018)

292.5m

Gross profit margin (FY, 2018), %

65.7%

Net income (FY, 2018)

2.9m

EBIT (FY, 2018)

(852.0k)

Market capitalization (22-Mar-2019)

5.5b

Closing stock price (22-Mar-2019)

158.0

Cash (31-Dec-2018)

67.9m
Penumbra's current market capitalization is $5.5 b.
Annual
USDFY, 2015FY, 2016FY, 2017FY, 2018

Revenue

186.1m263.3m333.8m444.9m

Revenue growth, %

41%

Cost of goods sold

62.0m92.5m116.6m152.4m

Gross profit

124.1m170.8m217.1m292.5m
Quarterly
USDQ3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

50.4m57.9m65.1m67.2m73.2m80.6m83.9m102.7m109.6m111.8m

Cost of goods sold

16.9m18.0m23.6m24.3m25.5m29.7m29.1m36.1m37.4m36.8m

Gross profit

33.5m39.9m41.5m42.9m47.7m50.9m54.8m66.6m72.3m75.0m

Gross profit Margin, %

66%69%64%64%65%63%65%65%66%67%
Annual
USDFY, 2015FY, 2016FY, 2017FY, 2018

Cash

19.5m13.2m50.6m67.9m

Accounts Receivable

57.2m47.7m

Inventories

56.8m73.0m94.9m115.7m

Current Assets

244.4m263.8m382.2m410.7m
Annual
USDFY, 2015FY, 2016FY, 2017FY, 2018

Net Income

2.4m14.8m4.7m2.9m

Depreciation and Amortization

1.8m2.3m3.8m6.2m

Inventories

(25.1m)(19.7m)(18.8m)(22.3m)

Accounts Payable

132.0k1.4m1.9m1.3m
Quarterly
USDQ3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Net Income

732.0k780.0k965.0k(141.0k)(3.1m)(4.7m)(4.4m)5.5m18.9m

Depreciation and Amortization

1.2m538.0k1.1m1.8m654.0k1.4m2.6m1.4m2.9m4.5m

Inventories

(18.0m)(9.1m)(12.0m)(14.0m)(6.1m)(6.8m)(14.7m)208.0k(3.9m)(15.4m)

Accounts Payable

1.5m1.4m1.3m947.0k889.0k293.0k873.0k622.0k625.0k1.7m
USDY, 2018

Revenue/Employee

202.2k

Financial Leverage

1.2 x
Show all financial metrics
Report incorrect company information

Penumbra Online and Social Media Presence

Embed Graph
Report incorrect company information

Penumbra News and Updates

Penumbra, Inc. Appoints Janet Leeds and Surbhi Sarna to its Board of Directors

ALAMEDA, Calif., Jan. 18, 2019 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that two new Board members were appointed to its Board of Directors (the "Board") on January 17, 2019. Ms. Janet Leeds was appointed to the Board as a Class I director, effective immediately, and Ms. ...

Penumbra, Inc. to Present at the 37th Annual J.P. Morgan Healthcare Conference

ALAMEDA, Calif., Dec. 20, 2018 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Tuesday, January 8, 2019. Event: 37th Annual J.P. Morgan Healthcare...

Penumbra, Inc. to Present at the BMO Prescriptions for Success Healthcare Conference

ALAMEDA, Calif., Nov. 29, 2018 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the BMO Prescriptions for Success Healthcare Conference in New York, NY on Wednesday, December 12, 2018. Event: BMO Prescriptions for Success...

Global Interventional Neurology Market Development Status and Growth Forecast 2024 Analysis By Medtronic, Inc. (Covidien), Penumbra, Inc., Stryker Corporation, Johnson & Johnson and Terumo Corporation

Summary This report includes market status and forecast of global and major regions, with the introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. Posted via Industry Today. Follow us on Twitter @Indu…

Penumbra, Inc. Schedules Third Quarter 2018 Earnings Release and Conference Call for November 5, 2018

ALAMEDA, Calif., Oct. 15, 2018 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the third quarter 2018 after market close on Monday, November 5, 2018 at 5:00 PM Eastern Time. A press release with third quarter...

Neurovascular Devices 2018 Global Market Key Players – Stryker Corporation, Johnson & Johnson, Medtronic, Terumo, Penumbra – Analysis and Forecast to 2025

WiseGuyRerports.com Presents “Global Neurovascular Devices Market Research Report 2018” New Document to its Studies Database Posted via Industry Today. Follow us on Twitter @IndustryToday
Show more
Report incorrect company information

Penumbra Frequently Asked Questions

  • When was Penumbra founded?

    Penumbra was founded in 2004.

  • How many employees does Penumbra have?

    Penumbra has 2,200 employees.

  • What is Penumbra revenue?

    Latest Penumbra annual revenue is $444.9 m.

  • What is Penumbra revenue per employee?

    Latest Penumbra revenue per employee is $202.2 k.

  • Who are Penumbra competitors?

    Competitors of Penumbra include Stryker, E-Qure and Obalon Therapeutics.

  • Where is Penumbra headquarters?

    Penumbra headquarters is located at 1321 Harbor Bay Pkwy, Alameda.

  • Where are Penumbra offices?

    Penumbra has offices in Alameda, New York, Melbourne, Livermore and in 6 other locations.

  • How many offices does Penumbra have?

    Penumbra has 12 offices.